Making clinical research crystal clear

Clinical trial transparency services

Clinical trial transparency (CTT) obligations are foundational to your company’s commitment to patient centricity. Achieving compliance with diverse and evolving global regulations is challenging and requires:
  • A deep understanding of how the regulations impact individual clinical studies and company processes.
  • The ability to apply this knowledge to create disclosure documents that are “right first time”.
  • Monitoring the progress of all disclosure documents across your clinical trial portfolio.
Krystelis offers comprehensive services to help you meet these obligations. Our proven approach has evolved over our decades of experience in this area.
Krystelis-Clinical-trial-transparency-services-Image

Services offered

National and International Clinical Trial Registry Services Icon

National and international clinical trial registry services

Our comprehensive services for clinical trial registries include:
Transparency compliance monitoring Icon

Transparency compliance monitoring

Study tracking and CTT compliance monitoring is integral to all CTT activities. We take full accountability for compliance by:
  • Assessing CTT obligations at the study or marketing authorisation application (MAA)-level
  • Creating robust plans to meet the transparency obligations
  • Regularly monitoring progress and mitigating risks encountered
Redaction and Anonymisation Services Icon

Redaction and anonymisation services

We offer end-to-end support for redaction and anonymization to comply with growing data and document sharing requirements (European Clinical Trial Regulation (EU CTR) 536/2014, EMA Policy 0070, EMA Policy 0043, Health Canada Public Release of Clinical Information (HC PRCI), and voluntary data sharing requests).

Our services include:

  • Liaising directly with Health Authorities
  • Assessment of source documents for protection of personal data (PPD)
  • Re-identification risk-assessment
  • Preparation of an anonymisation plan
  • Identification of commercially confidential information (CCI)
  • Validation of CCI through literature searches
  • Anonymisation/redaction of PPD
  • Redaction of CCI and preparation of justification table/proposed redaction control sheet
  • Preparation of the anonymisation report

Click here for more information on our redaction and anonymisation services

Plain language summary (PLS) services Icon

Plain language summary (PLS) services

We offer end-to-end PLS services:
  • Plain language protocol synopses
  • Plain language summaries for clinical trial results
  • Plain language summaries for publications
  • Implementing processes for PLSs
  • Health literacy review
  • Graphic design support (infographics and template design)
  • Comic or video formats of summaries
  • Review of material by a patient representative panel (patient panel review) or public representatives (non-scientific panel review)

Click here for more information on our plain language services.

Transparency regulatory consulting Icon

Transparency regulatory consulting

Our comprehensive understanding of transparency regulations and in-depth experience in this area for the past 17 years allows us to provide expert advice and unique insights on dealing with challenging situations related to CTT.
Click here for more information on our consulting services.
Section-Bottom-Bg-shape

Experience of our experts

Have been working in CTT for over two decades

Deep understanding of current and emerging global regulatory requirements

Extensive experience working with regulatory/registry reviewers

Completed thousands of transparency deliverables across all therapeutic areas and phases of drug development

Significant contributions to industry forums and the development of regulations

Produced publications, white papers, and posters on CTT developments

CTA-Bg-Shape-Orange
INTERESTED IN LEARNING MORE?

Get In Touch

CTA-Bg-Shape-Blue